1. 21st Century Cures Act Victory

    As Vice President of LLS’s Office of Public Policy, Bernadette O’Donoghue leads strategic public policy development at the federal and state levels, providing input from patients to help improve access to care and accelerate cures. This week was a monumental victory for cancer patients. The 21st Century Cures Act, which will significantly speed access to new lifesaving therapies, was signed into a law. Now, cancer patients, survivors and their families are closer to improved diagnosti...

    Read More
  2. What is Medicare?

    By Abby Henry, Oncology Content Manager, PearlPoint Cancer Support Medicare is an insurance program run by the United States government. Medicare is for people who 65 years or older Under 65 but have received Social Security Disability Insurance (SSDI) for 24 months Have end-stage renal disease or Amyotrophic Lateral Sclerosis (ALS) Medicare has 4 types of possible coverage. Part A (Hospital Insurance): Part A covers inpatient care such as hospital care, nursin...

    Read More
  3. #ASH16 (Blog 3): Teaming Up to Beat AML

    This is the third in a series of blogs covering the 58th ASH Annual Meeting and Exposition (#ASH16). LLS’s groundbreaking precision medicine clinical trial in acute myeloid leukemia (AML), “has the potential to change the paradigm of AML and other hematologic malignancies,” said Kenneth Anderson, M.D., Dana-Farber Cancer Institute, during a press briefing today at the 58th ASH Annual Meeting and Exhibition in San Diego. Dr. Anderson, president-elect of ASH (the American Socie...

    Read More
  4. #ASH16 (Blog 2): Innovations in AML and Surprising Results for CML

    This is the second of a series of blogs covering the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) conference over the next few days. Check back for more news from the meeting. On the first official day of the 58th ASH Annual Meeting and Exposition here in San Diego, scientists from around the world introduced new data from clinical trials for blood cancer therapies. Numerous results offer hope of transforming the way patients are treated and many presentations included ...

    Read More
  5. #ASH16 (Blog 1): Is the Best Yet to Come in Immunotherapy?

    This is the first of a series of blogs covering the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) conference over the next few days. Check back for more news from the meeting. Harnessing a patient’s immune system to fight cancer is a hot topic. So hot, in fact, that today’s Leukemia & Lymphoma Society (LLS) satellite symposium on the topic preceding the 58th ASH Annual Meeting and Exposition in San Diego (#ASH16) was at capacity with more than 600 attendees. The L...

    Read More
  6. A Special Delivery for Mom with Cancer

    On April 8, 2016, I was diagnosed with acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). I was 23 weeks pregnant. For almost five years, my husband, Allan, and I battled unexplained infertility. After three failed fertility treatments, we finally found ourselves pregnant the “au natural” way! At 18 weeks, I was diagnosed with a liver disorder and went for frequent blood work to ensure my liver was responding to the treatment. One of these blood tests re...

    Read More